Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis

NCT01378429 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

89

Enrollment

INDUSTRY

Sponsor class

Conditions

Perennial Allergic Rhinitis
PAR

Interventions

DRUG: ciclesonide nasal aerosol
DRUG: Placebo

Sponsor

Sumitomo Pharma America, Inc.